# Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent

> **NCT01511198** · PHASE2 · COMPLETED · sponsor: **Novo Nordisk A/S** · enrollment: 223 (actual)

## Conditions studied

- Diabetes
- Diabetes Mellitus, Type 2

## Interventions

- **DRUG:** liraglutide
- **DRUG:** metformin

## Key facts

- **NCT ID:** NCT01511198
- **Lead sponsor:** Novo Nordisk A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2001-02
- **Primary completion:** 2001-10
- **Final completion:** 2001-10
- **Target enrollment:** 223 (ACTUAL)
- **Last updated:** 2017-01-26


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01511198

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01511198, "Efficacy and Safety of Metformin and Liraglutide in Obese Subjects With Type 2 Diabetes Previously Treated With an Oral Hypoglycemic Agent". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT01511198. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*